跳至主要内容
临床试验/NCT01358604
NCT01358604已完成不适用

ROR1 as a Novel Target for Neuroblastoma

Children's Oncology Group0 个研究点目标入组 20 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
主要终点
ROR1 is expressed on the surface of neuroblastoma cells and constitutes a suitable target for mAb therapy

研究概览

简要总结

RATIONALE: Studying samples of tissue and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study studies biomarkers in samples from young patients with neuroblastoma.

详细描述

OBJECTIVES:

Primary

  • To analyze the expression of ROR1 on the surface of primary neuroblastoma cells.
  • To investigate the therapeutic potential of anti-ROR1 monoclonal antibodies (mAbs), bispecific antibodies, and immunotoxins in in vitro and in vivo models of neuroblastoma.

OUTLINE: Archived bone marrow and tumor tissue samples are analyzed for ROR1 expression by flow cytometry, western blotting, qPCR, and IHC.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
— 至 120 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

ROR1 is expressed on the surface of neuroblastoma cells and constitutes a suitable target for mAb therapy

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

相似试验

Biomarkers in Samples From Young Patients With... | 临床试验